Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Y Graham

Showing results (471-480 of 635) with videos related to

Pageof 64
Sort By:
Alimentary Pharmacology & Therapeutics|September 12, 2017
Systematic review with meta-analysis: the global recurrence rate of Helicobacter pyloriY Hu, J-H Wan, X-Y Li, et al.
Gastrointestinal Endoscopy|March 1, 1996
Detection of Helicobacter pylori by rapid urease tests: is biopsy size a critical variable?M M Yousfi, H M El-Zimaity, R A Cole, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 5, 2000
Proinflammatory activation of neutrophils and monocytes by Helicobacter pylori is not associated with cagA, vacA or picB genotypesP S Hansen, M F Go, K Varming, et al.
Digestive Diseases and Sciences|January 1, 1995
Determination of Helicobacter pylori status by reverse transcription-polymerase chain reaction. Comparison with urea breath testF A el-Zaatari, A M Nguyen, R M Genta, et al.
Gastrointestinal Endoscopy|June 1, 1987
Gastroscopic localization of a microencapsulated KCl preparation in the human stomachD Y Graham, J L Smith, R D Jones, et al.
The American Journal of Gastroenterology|September 14, 1999
Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodiesM T Al-Assi, K Miki, J H Walsh, et al.
Alimentary Pharmacology & Therapeutics|April 2, 1999
Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infectionD Y Graham, J Hoffman, S Y Anderson, et al.
Scandinavian Journal of Gastroenterology|September 1, 1991
Transmission of Helicobacter pylori infection. Studies in families of healthy individualsH M Malaty, D Y Graham, P D Klein, et al.
Gastroenterology|June 1, 1991
Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic statusD Y Graham, H M Malaty, D G Evans, et al.
Archives of Internal Medicine|May 18, 2001
Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United StatesM S Osato, R Reddy, S G Reddy, et al.
Pageof 64

Showing results (471-480 of 635) with videos related to

Sort By:
Pageof 64
Alimentary Pharmacology & Therapeutics|September 12, 2017
Systematic review with meta-analysis: the global recurrence rate of Helicobacter pyloriY Hu, J-H Wan, X-Y Li, et al.
Gastrointestinal Endoscopy|March 1, 1996
Detection of Helicobacter pylori by rapid urease tests: is biopsy size a critical variable?M M Yousfi, H M El-Zimaity, R A Cole, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 5, 2000
Proinflammatory activation of neutrophils and monocytes by Helicobacter pylori is not associated with cagA, vacA or picB genotypesP S Hansen, M F Go, K Varming, et al.
Digestive Diseases and Sciences|January 1, 1995
Determination of Helicobacter pylori status by reverse transcription-polymerase chain reaction. Comparison with urea breath testF A el-Zaatari, A M Nguyen, R M Genta, et al.
Gastrointestinal Endoscopy|June 1, 1987
Gastroscopic localization of a microencapsulated KCl preparation in the human stomachD Y Graham, J L Smith, R D Jones, et al.
The American Journal of Gastroenterology|September 14, 1999
Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodiesM T Al-Assi, K Miki, J H Walsh, et al.
Alimentary Pharmacology & Therapeutics|April 2, 1999
Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infectionD Y Graham, J Hoffman, S Y Anderson, et al.
Scandinavian Journal of Gastroenterology|September 1, 1991
Transmission of Helicobacter pylori infection. Studies in families of healthy individualsH M Malaty, D Y Graham, P D Klein, et al.
Gastroenterology|June 1, 1991
Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic statusD Y Graham, H M Malaty, D G Evans, et al.
Archives of Internal Medicine|May 18, 2001
Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United StatesM S Osato, R Reddy, S G Reddy, et al.
Pageof 64